iShares US Pharmaceuticals ETF
ETFYour view on IHE
iShares US Pharmaceuticals ETF
ETFISharesSentiment
AUM (USD)
$1.64B
Expense Ratio
0.37%
Holdings
56
Sentiment
Overview for iShares US Pharmaceuticals ETF
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- May 1, 2006
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- May 1, 2006
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- IShares
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- May 1, 2006
- Domicile
- US
About this fund
The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
IHE Stock Price
Key Facts
EquityExpense Ratio
0.37%
AUM
$1.64B
Fund Details
Expense Ratio
0.37%
Assets Under Management
$1.64B
NAV
$102.50 USD
Holdings
56
Average Volume
204.8K
Inception Date
May 1, 2006
Asset Class
Equity
Fund Issuer
IShares
Domicile
US
ISIN
US4642888360
CUSIP
464288836
NAV Currency
USD
Expense Ratio
0.37%
Assets Under Management
$1.64B
NAV
$102.50 USD
Holdings
56
Average Volume
204.8K
Inception Date
May 1, 2006
Asset Class
Equity
Fund Issuer
IShares
Domicile
US
ISIN
US4642888360
CUSIP
464288836
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.